down arrow

OneSource Speci.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE013P01021
  • NSEID: ONESOURCE
  • BSEID: 544292
INR
1,496.75
16.75 (1.13%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 67.31 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

67.31 k (-32.17%) Volume

Shareholding (Dec 2024)

FII

17.44%

Held by 232 FIIs

DII

12.56%

Held by 14 DIIs

Promoter

37.77%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 17,128 Cr (Mid Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

1.41

stock-summary
Return on Equity

-61.18%

stock-summary
Price to Book

41.61

Revenue and Profits (1 Year):
Net Sales:
393 Cr
(Quarterly Results - Dec 2024)
Net Profit:
-69 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Icon
Company does not have enough history
Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
100.30%
EBIT Growth (5y)
-22.75%
EBIT to Interest (avg)
-1.83
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.07
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
9.58%
Institutional Holding
30.00%
ROCE (avg)
-12.85%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
33
Price to Book Value
41.61
EV to EBIT
-106.88
EV to EBITDA
-200.06
EV to Capital Employed
17.88
EV to Sales
101.84
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-16.73%
ROE (Latest)
-61.18%
Tecnicals key factors
Indicator
Weekly
Monthly
Icon
No records
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

9.5759

Mutual Funds

Held by 13 Schemes (4.62%)

FIIs

Held by 232 FIIs (17.44%)

Promoter with highest holding

Tenshi Pharmaceuticals Private Limited (20.82%)

Highest Public shareholder

Medella Holdings Pte. Ltd. (4.17%)

Individual Investors Holdings

13.05%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 37.22% vs 213.05% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -26.14% vs -80.34% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "336.75",
          "val2": "245.40",
          "chgp": "37.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "100.38",
          "val2": "22.19",
          "chgp": "352.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "43.92",
          "val2": "44.11",
          "chgp": "-0.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-100.52",
          "val2": "-6.78",
          "chgp": "-1,382.60%",
          "chgp_class": "negative"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-73.02",
          "val2": "-57.89",
          "chgp": "-26.14%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "29.81%",
          "val2": "9.04%",
          "chgp": "20.77%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "146.37",
          "val2": "42.57",
          "chgp": "243.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "6.72",
          "val2": "-75.16",
          "chgp": "108.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "41.11",
          "val2": "42.98",
          "chgp": "-4.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.41",
          "val2": "-66.10",
          "chgp": "97.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-72.12",
          "val2": "-220.35",
          "chgp": "67.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "4.59%",
          "val2": "-176.56%",
          "chgp": "181.15%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "483.12",
          "val2": "98.78",
          "chgp": "389.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "107.10",
          "val2": "-85.49",
          "chgp": "225.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "85.03",
          "val2": "68.99",
          "chgp": "23.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-101.93",
          "val2": "-141.38",
          "chgp": "27.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-145.14",
          "val2": "-350.39",
          "chgp": "58.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "22.17%",
          "val2": "-86.55%",
          "chgp": "108.72%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 344.12% vs -69.80% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 51.09% vs -246.01% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "171.92",
          "val2": "38.71",
          "chgp": "344.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-88.24",
          "val2": "-160.69",
          "chgp": "45.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "89.45",
          "val2": "47.55",
          "chgp": "88.12%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-141.41",
          "val2": "-528.62",
          "chgp": "73.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-391.17",
          "val2": "-799.83",
          "chgp": "51.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-51.33%",
          "val2": "-415.11%",
          "chgp": "363.78%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
336.75
245.40
37.22%
Operating Profit (PBDIT) excl Other Income
100.38
22.19
352.37%
Interest
43.92
44.11
-0.43%
Exceptional Items
-100.52
-6.78
-1,382.60%
Standalone Net Profit
-73.02
-57.89
-26.14%
Operating Profit Margin (Excl OI)
29.81%
9.04%
20.77%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 37.22% vs 213.05% in Sep 2024

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2024 is -26.14% vs -80.34% in Sep 2024

Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
146.37
42.57
243.83%
Operating Profit (PBDIT) excl Other Income
6.72
-75.16
108.94%
Interest
41.11
42.98
-4.35%
Exceptional Items
-1.41
-66.10
97.87%
Standalone Net Profit
-72.12
-220.35
67.27%
Operating Profit Margin (Excl OI)
4.59%
-176.56%
181.15%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
483.12
98.78
389.09%
Operating Profit (PBDIT) excl Other Income
107.10
-85.49
225.28%
Interest
85.03
68.99
23.25%
Exceptional Items
-101.93
-141.38
27.90%
Standalone Net Profit
-145.14
-350.39
58.58%
Operating Profit Margin (Excl OI)
22.17%
-86.55%
108.72%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
171.92
38.71
344.12%
Operating Profit (PBDIT) excl Other Income
-88.24
-160.69
45.09%
Interest
89.45
47.55
88.12%
Exceptional Items
-141.41
-528.62
73.25%
Consolidate Net Profit
-391.17
-799.83
51.09%
Operating Profit Margin (Excl OI)
-51.33%
-415.11%
363.78%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 344.12% vs -69.80% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 51.09% vs -246.01% in Mar 2023

stock-summaryCompany CV
About OneSource Specialty Pharma Ltd stock-summary
stock-summary
OneSource Specialty Pharma Ltd
Mid Cap
Pharmaceuticals & Drugs
Onesource Specialty Pharma Limited was incorporated as a Private Limited Company, with the name and style of `Inbiopro Solutions Private Limited' dated June 12, 2007, was issued by the Registrar of Companies, Karnataka at Bangalore. The Company name was then changed to `Stelis Biopharma Private Limited', pursuant to a Scheme of Amalgamation and a Certificate of Incorporation dated December 24, 2014, was issued by the Registrar of Companies.
Company Coordinates stock-summary
Icon
No Company Details Available